Literature metadata

A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia.↗

PubMed lists PMID 42713641 in NEJM evidence as Journal Article, Clinical Trial, Phase III, Randomized Controlled Trial, Multicenter Study, with publication-date metadata of 2026-09-09 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Exact source context

What this record can answer

This retained PubMed record can answer what the index contains about this citation, including its title and publication metadata. It does not by itself establish the article’s findings.

PubMed PMID 42713641 · Open source record ↗

Article title

A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia.

Continue with profile context

These profile links provide broader, bounded context while keeping this source record’s identity and version separate.

Update · November 16, 2026

PubMed revised the bibliographic metadata of PMID 42713641, with a metadata revision date of 2026-11-09. This version reports that observation; the earlier retained observation remains available as version 1. 1

This version supersedes public version 1.

PubMed lists PMID 42713641 in NEJM evidence as Journal Article, Clinical Trial, Phase III, Randomized Controlled Trial, Multicenter Study, with publication-date metadata of 2026-09-09 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. 1

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. 1

What this source can tell us. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. The source title and publication details are not an endorsement or a summary of the article's findings.

Sources and evidence

  1. 1

Preserved public versions

Earlier versions of this record

Every earlier public version is kept here with its original wording and sources. The current version above supersedes them.

Superseded public version 1

Version 1: A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia.↗

PubMed lists PMID 42713641 in NEJM evidence as Journal Article, with publication-date metadata of 2026-09-09 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

PubMed lists PMID 42713641 in NEJM evidence as Journal Article, with publication-date metadata of 2026-09-09 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. 1

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. 1

Sources for version 1

  1. 1